Fiera Capital (Canada)
BPMC

Fiera Capital (Canada)’s Blueprint Medicines BPMC Stock Holding History

Fiera Capital (Canada)’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,635
Closed -$1.69M – 667
2018
Q3 		$1.69M Sell
21,635
-13,490
-38% -$938K 0.01% 440
2018
Q2 		$2.23M Buy
+35,125
New +$2.8M 0.01% 401

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Fiera Capital (Canada)'s BPMC Position: Q4 2018 in Review

Fiera Capital (Canada) sold out of Blueprint Medicines (BPMC) in Q4 2018, closing a stake of 21,635 shares — an estimated $1.69M sold.

Fiera Capital (Canada) first reported a position in BPMC in Q2 2018 and held it in 2 quarters. The position peaked at $2.23M in Q2 2018. 162 funds tracked by Wall St. Rank hold BPMC as of Q4 2018.

  • Fiera Capital (Canada) reported no remaining Blueprint Medicines position as of Q4 2018 after selling out during the quarter.
  • Fiera Capital (Canada) sold 21,635 Blueprint Medicines shares in Q4 2018, an estimated $1.69M.
  • Fiera Capital (Canada) first reported a position in Blueprint Medicines in Q2 2018 and held it in 2 quarters.
  • Fiera Capital (Canada)'s Blueprint Medicines position peaked at $2.23M in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2018.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2018, filed 12 Feb 2019.